Hot Stocks
Thursday, November 17, 2016
UPDATE 1-No early win for Sanofi, Regeneron cholesterol drug in study
Nov 17 (Reuters) - Sanofi and Regeneron
Pharmaceuticals said on Thursday they would continue a
large clinical outcomes study with their injectable
cholesterol-lowering drug Praluent, confounding...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment